GLYCOPYRROLATE MSDS PDF

GLYCOPYRROLATE MSDS PDF

SAFETY DATA SHEET. PRODUCT: Glycopyrrolate Injection USP. Section 1: PRODUCT AND COMPANY INFORMATION. 54/1, Boodhihal village,. Nelamangala. Glycopyrrolate. 1-Methylpyrrolidyl alpha-phenylcyclopentaneglycolate methobromide;. Glycopyrrolate bromide; Glycopyrronium bromide. Glycopyrronium (as the bromide salt glycopyrrolate) is a synthetic anticholinergic agent In October , glycopyrrolate was approved by the FDA for use as a FDA label. Download ( KB). MSDS. Download ( KB).

Author: Kazilkis Vibar
Country: Peru
Language: English (Spanish)
Genre: Video
Published (Last): 6 September 2013
Pages: 244
PDF File Size: 5.76 Mb
ePub File Size: 3.91 Mb
ISBN: 940-4-77440-248-6
Downloads: 30923
Price: Free* [*Free Regsitration Required]
Uploader: Voodookazahn

The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Dronabinol. Oxybutynin The risk or severity of adverse mads can be increased when Oxybutynin is combined with Glycopyrronium. Ibipinabant The risk or severity of Glycopyrrolaet and msdw can be increased when Glycopyrronium is combined with Ibipinabant. Sodium phosphate, monobasic The therapeutic efficacy of Sodium phosphate, monobasic can be decreased when used in combination with Glycopyrronium.

Orciprenaline The risk or severity of Tachycardia can be increased when Orciprenaline is combined with Glycopyrronium. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Prenalterol. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Anisodamine. Octopamine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Octopamine.

Glycopyrronium

The risk or severity of adverse effects can be increased when Dimetindene is combined with Glycopyrronium. Gallamine Glycopyrronium may increase the anticholinergic activities of Gallamine. The risk or severity of adverse effects can be increased when Camylofin is combined with Glycopyrronium.

The therapeutic efficacy of Magnesium can be decreased when used in combination with Glycopyrronium. Tobramycin The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Tobramycin. Methylcellulose The therapeutic efficacy of Methyl cellulose can be decreased when used in combination with Glycopyrronium. The risk or severity of adverse effects can be increased when Lamotrigine is combined with Glycopyrronium.

  JUNOT DIAZ EDISON NEW JERSEY PDF

Etilefrine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Etilefrine. Glycine betaine The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Glycine betaine. The risk or severity of adverse effects can be increased when Etybenzatropine is combined with Glycopyrronium.

Detomidine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Detomidine. Romifidine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Romifidine. Micronomicin The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Micronomicin. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Clenbuterol.

Sodium iodide The therapeutic efficacy of Sodium iodide can be decreased when used in combination with Glycopyrronium.

Glycopyrronium – DrugBank

Ritodrine The risk or severity of Tachycardia can mds increased when Ritodrine is combined with Glycopyrronium.

Pirenzepine The risk or severity of adverse effects can be increased when Pirenzepine is combined with Glycopyrronium. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Cirazoline. Distigmine The therapeutic efficacy of Glycopyrronium can be decreased when used in combination with Distigmine. Fenpiverinium The risk or severity of adverse effects can be increased when Fenpiverinium is combined with Glycopyrronium.

Bitolterol The risk or severity of Tachycardia can be increased when Bitolterol is combined with Glycopyrronium. The risk or severity of adverse effects can be increased when Glycopyrronium is combined with Nalbuphine.

Mephedrone The risk or severity of Tachycardia can mmsds increased when Glycopyrronium is combined with Mephedrone. The risk or severity of adverse effects can be increased when Orphenadrine is combined with Glycopyrronium. The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Ephedrine. Diethylpropion The risk or severity of Tachycardia can be increased when Diethylpropion is combined with Glycopyrronium.

  ARCHITECTURAL THEORY AN ANTHOLOGY FROM VITRUVIUS TO 1870 PDF

Plecanatide The therapeutic efficacy of Plecanatide can be decreased when used in combination with Glycopyrronium. Barbital Glycopyrronium may increase the anticholinergic activities of Barbital.

Agmatine Glycopyrronium may increase the anticholinergic activities of Agmatine.

Procyclidine The risk or severity of adverse effects can be increased when Procyclidine is combined with Glycopyrronium. The risk or severity of Tachycardia and drowsiness can be increased when Glycopyrronium is combined with Cannabidiol. Bromocriptine The risk or severity of Tachycardia can be increased when Glycopyrronium is combined with Bromocriptine.

The risk or severity of adverse effects can be increased when Flavoxate is glycopyrrolare with Glycopyrronium. Emetonium iodide The risk or severity of adverse effects can be increased when Emetonium iodide is combined with Glycopyrronium. The risk or severity of adverse effects can be increased when Mdss is combined with Glycopyrronium. Diphemanil Methylsulfate The risk or severity of adverse effects can be increased when Diphemanil Methylsulfate is combined with Glycopyrronium.

Hydrochlorothiazide Glycopyrolate serum concentration of Hydrochlorothiazide can be increased when it is combined with Glycopyrronium.

Methscopolamine The risk or severity of adverse effects can be increased when Methscopolamine is combined with Glycopyrronium. Chloroprocaine Glycopyrronium may increase the anticholinergic activities of Chloroprocaine. Nicardipine The risk or severity of adverse effects can be increased when Nicardipine is glycopyrrolatte with Glycopyrronium.